title: Red cell substitutes: present status.
authors.forename: L R
authors.initials: LR
authors.lastname: Sehgal
authors.forename: H L
authors.initials: HL
authors.lastname: Sehgal
authors.forename: S A
authors.initials: SA
authors.lastname: Gould
authors.forename: A L
authors.initials: AL
authors.lastname: Rosen
authors.forename: R
authors.initials: R
authors.lastname: DeWoskin
authors.forename: G S
authors.initials: GS
authors.lastname: Moss
mesh_terms: D000818:Animals; D001802:Blood Substitutes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005466:Fluorocarbons / Q000627:therapeutic use; D006454:Hemoglobins / Q000627:therapeutic use; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D012996:Solutions
chemical_list: D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006454:Hemoglobins; D006895:Hydroxyethyl Starch Derivatives; D012996:Solutions; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination